Lovelace Biomedical has launched operations as a preclinical contract research organization (CRO), offering toxicology, pharmacology and other services to pharmaceutical and biotechnology companies. Preclinical services and expertise span the fields of respiratory disease, infectious disease, gene therapy, neuroscience, alternative tobacco products and medical countermeasures, as well as drug discovery. Lovelace Biomedical draws on nearly seven decades of leadership in scientific research exp...